Primevision Pharma LLP
About Primevision Pharma LLP
Data last updated:
Primevision Pharma LLP is a limited liability partnership (LLP) based in Miraj, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 February 2022.
The LLP is registered with the Registrar of Companies (ROC), Pune, under LLPIN ABA-4515. Its GSTIN is 27ABBFP5368E1Z5 (Maharashtra).
The LLP has a total obligation of contribution of ₹2 Cr. It is led by designated partners including Atul Shashikant Dhanavade and Ashishkumar Ramchandra Kore.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Plot No. 28; Flat No. 206; Nirmiti Tower Near Dr. Sanjeev Kulkarni Hospital, Miraj, Maharashtra, India – 416410.
As per MCA filings, the LLP has open charges of ₹14.3 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 28; Flat No. 206; Nirmiti Tower Near Dr. Sanjeev Kulkarni Hospital, Miraj, Maharashtra, India – 416410
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Primevision Pharma LLP FY 2025 filings available
Financial Statement Summary of Primevision Pharma LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• |
| Assets and Liabilities | ||||
| Partners' Contribution | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Primevision Pharma LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Primevision Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Primevision Pharma LLP
Primevision Pharma has 7 current designated partners and 2 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Shashikant Dhanavade | Designated Partner | 01 Feb 2022 | 4 Years 8 Months | Current |
| Ashishkumar Ramchandra Kore | Designated Partner | 01 Feb 2022 | 4 Years 8 Months | Current |
| Yogesh Veerabhadra Mirji Also directs: Eleazar Clinical Pharmacy LLP | Designated Partner | 18 Mar 2022 | 4 Years 6 Months | Current |
| Vijay Kallappa Magdum | Designated Partner | 18 Mar 2022 | 4 Years 6 Months | Current |
| Rajendrakumar Bhagvant Dhanavade | Designated Partner | 18 Mar 2022 | 4 Years 6 Months | Current |
| Chetan Suresh Sankh | Designated Partner | 18 Mar 2022 | 4 Years 6 Months | Current |
Charges & Borrowings of Primevision Pharma LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2022 | Bank of India | ₹14.3 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Primevision Pharma LLP
Employment history and EPFO contributions of people linked to Primevision Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Primevision Pharma LLP
Primevision Pharma LLP has 9 designated partner changes on record since 2022: 9 appointments. The latest: Chetan Suresh Sankh was appointed as Designated Partner on 18 Mar 2022.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Primevision Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Primevision Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Primevision Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Primevision Pharma LLP
Primevision Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABBFP5368E1Z5 | Maharashtra | Active | 16 Mar 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Primevision Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Primevision Pharma LLP
Primevision Pharma is an active limited liability partnership based in Miraj, Maharashtra, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 01 February 2022 (4+ years old) and is registered under LLPIN ABA-4515.
Primevision Pharma has 7 current designated partners:
- Atul Shashikant Dhanavade - Designated Partner
- Ashishkumar Ramchandra Kore - Designated Partner
- Yogesh Veerabhadra Mirji - Designated Partner
- Vijay Kallappa Magdum - Designated Partner
- Rajendrakumar Bhagvant Dhanavade - Designated Partner
- Chetan Suresh Sankh - Designated Partner
- Niranjan Chandrashekhar Patil - Designated Partner
The GSTIN of Primevision Pharma is 27ABBFP5368E1Z5, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Primevision Pharma is ABA-4515. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Primevision Pharma was incorporated on 01 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Pune.
Chetan Suresh Sankh was appointed as Designated Partner on 18 Mar 2022. Rajendrakumar Bhagvant Dhanavade was appointed as Designated Partner on 18 Mar 2022. Sarthak Suresh Sankh was appointed as Partner on 18 Mar 2022. Primevision Pharma has 9 designated partner changes on record in total.
The registered office of Primevision Pharma is at Plot No. 28; Flat No. 206; Nirmiti Tower Near Dr. Sanjeev Kulkarni Hospital, Miraj, Maharashtra, India – 416410.
The total obligation of contribution is ₹2 Cr.
Primevision Pharma operates in the pharma industry, in the drug formulation and development segment.
Primevision Pharma has open charges of ₹14.3 Cr and no satisfied charges on record as per latest MCA filings.